Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 9.33M | 6.66M | 10.53M | 10.86M | 8.62M | 6.43M |
Gross Profit | 4.56M | 3.80M | 4.65M | 4.81M | 4.99M | 4.08M |
EBITDA | -3.85M | -4.03M | -2.84M | -3.81M | -3.09M | -2.89M |
Net Income | -4.48M | -5.14M | -3.86M | -4.82M | -3.65M | -4.20M |
Balance Sheet | ||||||
Total Assets | 12.21M | 11.74M | 12.56M | 16.56M | 21.77M | 17.71M |
Cash, Cash Equivalents and Short-Term Investments | 927.42K | 4.98M | 2.39M | 5.73M | 11.13M | 7.08M |
Total Debt | 3.17M | 2.33M | 2.66M | 2.78M | 3.15M | 2.84M |
Total Liabilities | 6.71M | 4.59M | 5.98M | 5.74M | 5.74M | 7.04M |
Stockholders Equity | 5.41M | 7.08M | 5.46M | 9.28M | 13.99M | 9.76M |
Cash Flow | ||||||
Free Cash Flow | -1.81M | -2.69M | -3.12M | -4.35M | -4.28M | -4.27M |
Operating Cash Flow | -1.50M | -2.35M | -2.63M | -3.59M | -3.52M | -4.07M |
Investing Cash Flow | -2.01M | -1.76M | -438.71K | -1.17M | -1.64M | -837.81K |
Financing Cash Flow | 187.11K | 6.58M | -278.79K | -430.02K | 8.98M | 1.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
55 Neutral | 23.78M | -1.49 | 0.00% | ― | -27.64% | 0.00% | |
50 Neutral | 6.11M | -14.09 | -36.08% | ― | 14.51% | 77.27% | |
50 Neutral | 15.71M | -14.97 | 0.00% | ― | 25.56% | 35.12% | |
45 Neutral | £10.96M | ― | -82.21% | ― | -38.36% | -4.92% | |
39 Underperform | 769.27K | -0.08 | -500.12% | ― | -38.73% | 96.64% | |
31 Underperform | 6.24M | -0.80 | 0.00% | ― | 0.00% | 0.00% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Directa Plus announced that its CEO, Giulio Cesareo, has acquired 28,600 ordinary shares, increasing his total interest to 4.24% of the company’s voting rights. This transaction underscores Cesareo’s confidence in the company’s future and may positively influence stakeholder perceptions, reinforcing Directa Plus’s position in the graphene industry.
Directa Plus reported a 15% revenue increase to approximately €3.9 million for the first half of 2025, along with a 40% reduction in EBITDA losses, reflecting strategic focus on high-value contracts and operational efficiencies. The company secured significant contract renewals and new agreements, including a major deal with OMV Petrom and a distribution agreement in the U.S. environmental market. Upcoming production upgrades are expected to enhance capabilities and expand market reach, particularly in the nano-graphite sector, supporting further growth and operational reliability.
Directa Plus announced that its CEO, Giulio Cesareo, has acquired 23,500 ordinary shares of the company, increasing his total interest to 4.21% of the company’s voting rights. This move reflects confidence in the company’s future prospects and may positively influence stakeholder perception, reinforcing the company’s stability and leadership in the graphene industry.
Directa Plus announced that its CEO, Giulio Cesareo, purchased 50,000 ordinary shares at 11.25 pence each, increasing his total interest to 4.19% of the company’s voting rights. This transaction reflects confidence in the company’s future and may positively influence stakeholder perception, reinforcing Directa Plus’s position in the graphene industry.
Directa Plus announced that Richard Hickinbotham, the Non-Executive Chairman, purchased 25,000 ordinary shares of the company, increasing his total interest to 291,666 shares, which represents 0.28% of the company’s total voting rights. This transaction underscores confidence in the company’s market position and potential growth, which could positively impact stakeholders and enhance Directa Plus’s industry standing.
Directa Plus announced that its CEO, Giulio Cesareo, has increased his stake in the company by purchasing 25,000 ordinary shares. This transaction raises his total interest to 4.14% of the company’s total voting rights, potentially signaling confidence in the company’s future prospects and impacting stakeholder perceptions.